Lartruvo

Lartruvo (olaratumab) — A PDGFRα blocker developed and marketed by Eli Lilly, used in combination with doxorubicin
for the treatment of soft tissue sarcoma.

Pullup banners

Brand guidelines

Brand Guidelines

Round table awareness brochure

Patient brochure

Reprint annotated guide

Journal reprint

Christina’s farewell card

There's an old cliché: when two people are in a relationship, they exchange jewelry — a ring, a necklace, a pendant. These small tokens have
a meaning that’s bigger than a piece of jewelry. They carry a sense of belonging.

And when that relationship ends, those pieces find their way home.

I used this idea to create a farewell card for our client Christina, who was leaving the brand after years together. Each photo features a brand team member wearing a piece of 'Christina' jewelry — the jewelry itself symbolic of the connection, the history, and everything
she meant to the team, now gently returned.

Next
Next

Nubeqa